K20 and 1080
at present, the popular cards for deep learning are rtx2080ti and rtx2070 (multi-channel), and it is not easy to buy more than one of them when gtx1080ti is delisted Second hand another)
* for the deep learning of CUDA platform, the graphics card mainly focuses on: single precision floating-point operation, video memory, tensor core (Turing architecture and volt architecture, RTX series and Titan V)
* in terms of the main stability and some special functions of Tesla, double precision (currently this deep learning is less used), single precision and half precision floating-point operation have little advantage, It's expensive (if you want to surpass gtx1080ti, you need tens of thousands of Tesla V100)
http://weibo.com/tv/v/F3ctzsvMm?fid=1034 :
it's not true. The annual income of bitcoin fund is determined by market demand
hope to adopt
It remains to be seen whether Kangmei pharmaceutical will lose its fortune On the evening of April 16, St Kangmei disclosed the correction announcement of the performance forecast, and the net profit in 2020 is expected to be about 24.48 billion yuan to 29.92 billion yuan. Previously, Kang Mei pharmaceutical estimated that the net loss was 14 billion 850 million yuan to 17 billion 820 million yuan, and in a short period of more than 2 months, the deficit increased by about ten billion yuan sharply. The reason for the loss of the company was attributed to the new crown virus epidemic and asset impairment. p>
of the nearly 30 billion cash "disappeared" before, 20.143 billion yuan was retroactively adjusted to the inventory account in the 2016 annual report on May 28, 2019. On the evening of April 16, the Shanghai Stock Exchange issued a "letter of concern", asking to explain the specific process of the company's asset impairment measurement, the specific time point of the impairment signs, whether there is insufficient provision in the early stage, false performance in the early stage or profit adjustment
this time, the regulatory authorities also sent a letter to ask the annual audit accountant of Kangmei pharmaceutical to issue a special explanation, and said that the company's net assets at the end of 2020 are expected to be negative, and the stock may be subject to delisting risk warning
as of the morning of April 19, St Kangmei, the former A-share "the first share of traditional Chinese medicine", had a total market value of only 9.749 billion yuan, and its share price was temporarily 1.96 yuan / share
on April 15, St Kangmei issued the announcement of Kangmei pharmaceutical on the failure of partial medium-term notes to be cashed on schele. At present, Kangmei pharmaceutical has a total of eight medium-term notes, except that the third issue will be cashed in 7893 months in 2022, the other five issues will be cashed before the end of June 2021
last year, the annual loss was greater than the total market value, and the net assets were about the same, so the payment of zhongpiao was imminent. Even if Kangmei pharmaceutical transferred its equity free of charge, it was difficult to fill the huge hole of deficit and debt
In any case, when the Chinese version of the class action system began to enter the full implementation stage, St Kangmei was "the first to bear the brunt". For its founders Ma Xingtian and Xu Dongjin, they created a new historyclass action solves the problem of protecting the rights of the majority of small investors. It remains to be seen whether the offenders who seriously damage the rights and interests of investors will be punished and let them lose their property, forcing the listed companies to strengthen corporate governance
{rrrrrrr}
extended information
the scale of small and medium-sized investors' claims against Kangmei pharmaceutical will be further expanded:
relevant announcements show that they bought Kangmei pharmaceutical shares through public bidding from April 20, 2017 (inclusive) to October 15, 2018 (inclusive) and still hold Kangmei pharmaceutical shares after closing on October 15, 2018, And investors with the same claim can register to join the lawsuit before April 25, 2021
the data shows that ring the period of time stipulated by the lawsuit, the number of shareholders of Kangmei Pharmaceutical Co., Ltd. exceeded 200000, holding an average of 16000 shares. According to the closing price of Kangmei pharmaceutical at 19.40 yuan on April 20, 2017, as of today, the loss of relevant investors is about 270000 yuan
At present, the court has not disclosed the compensation scale of class action. On December 31 last year, the Guangzhou court accepted the case of 11 plaintiffs jointly suing Kangmei pharmaceutical and its senior executives and other 22 defendants for Securities Misrepresentation liability dispute, and the plaintiff requested the court to judge the defendant for damages totaling about 410000 yuan. As more investors join the litigation, the scale of their claims will be further expandedworld of Warcraft
eternal tower
Zhuxian
DNF (hope to adopt
thank you)
There are some large enterprises that can solve many difficulties at the beginning of development and have better development prospects. Many large enterprises can be recognized by us, and we are very optimistic about these large enterprises
however, some enterprises may not be able to have better development, and may also be abandoned by the times, such as Kangmei pharmaceutical. Kangmei pharmaceutical was filed for bankruptcy and reorganization. How did it come to this point step by step? I think this enterprise has come to this stage for the following three reasons:
first, improper operation
in fact, I think the reason why this enterprise has come to this stage is that it can not have a better operation, nor can it have more business models, nor can it adjust its business direction, nor can it have more specific goals, so it will encounter more difficulties in the process of operation, But also can not solve such difficulties, which will make the enterprise can not have a better development, so it will graally decline{ RRRRR}
that's my opinion
[map of getting on and off] [SMS] [comments] [collection] [adoption (0)] 2. Take a taxi for 17.2 km, the cost is about 52 yuan. Note: the information is for reference only and can not be used as the basis for payment. This fee does not include toll and Bridge toll. Traffic jam and other factors may significantly increase the cost
[getting on and off map] [sending SMS] [comments] [collection] [adoption (0)] 3. Walk about 100 meters from Jiazhou square to Jiazhou Square Station (Guangfo highway), take Nanhai No. 236 (lift hands to stop, get off notice first) (take 15 stops), Nanhai No. 251 Foguang line (Jiaokou passenger station Xiqiao station) (take 15 stops) to Dazhen station, and then take Nanhai No. 259 (take 9 stops) to Science Museum Station. Walk back about 190 meters to Dongjian building
[map of getting on and off] [text message] [comment] [collection] [adoption (0)] 4. Walk about 100 meters from Jiazhou square to Jiazhou Square Station (Guangfo highway), take Nanhai 236 (lift hands to stop, get off notice first) (take 18 stops), Nanhai 251 Foguang line (Jiaokou passenger station Xiqiao station) (take 18 stops), Guangfo Chengba 18 line (original 666 Road) (no stop sign, lift hands to stop), Get off first notice (take 21 stops), Guangfo intersection Jiujiang bus station line (take 16 stops), Lanjing No.5 (some stations have no stop sign, only lift your hand to stop, get off first notice) (take 17 stops) to Foshan bridge (Le'an) station, transfer to No.138 (take 6 stops), Nanhai no.259 (take 6 stops) to Science Museum Station. Walk back about 190 meters to Dongjian building
[map of getting on and off] [SMS] [comments] [collection] [adoption (0)] 5. Walk about 100 meters from Jiazhou square to Jiazhou Square Station (Guangfo highway), take Guangfo Citybus line 18 (original No. 666) (no stop sign, only raise your hand, get off first notice) (take 12 stops) to Dali commercial pedestrian street station (g325), and then take Nanhai 259 (take 14 stops) to Science Museum Station. Walk back about 190 meters to Dongjian building
[map of getting on and off] [text message] [comment] [collection] [adoption (0)] 6. Walk 180 meters from Jiazhou square to Huanghai Road station, take No. 276 Foguang line (luochongwei - North Gate of Oriental square) (12 stops) to Nanhai book shopping center station, and then take No. 113 (16 stops) to Science Museum Station. Walk back about 190 meters to Dongjian building
[map of getting on and off] [text message] [comment] [collection] [adoption (0)] 7. Walk about 100 meters from Jiazhou square to Jiazhou Square Station (Guangfo highway), take No.277 Foguang line (southern tea market dongermin Park) (12 stops), Nanhai No.210 (16 stops) to Xingye Xincun station, and transfer to No.113 (18 stops) Nanhai 208 Road (take 19 stops) to Science Museum Station. Walk back about 190 meters to Dongjian building
[map of getting on and off] [SMS] [comments] [collection] [adoption (0)] 8. Walk 180 meters from Jiazhou square to Huanghai Road station, take No. 276 Foguang line (luochongwei - North Gate of Dongfang Square) (stop 21) to Dongfang Square Station, and then transfer to No. 104 (stop 4) to Science Museum Station. Walk about 240 meters to Dongjian building
[get on / off map] [send SMS] [comment] [collection] [adopt (0)] 9. Walk about 100 meters from Jiazhou square to Jiazhou Square Station (Guangfo highway), take Lanjing No.5 (some stations have no stop sign, you can only stop when you raise your hand, get off first notice) (take No.19 station) to Foshan railway station (bus station), then take No.124 (take No.5 station) to Chengmentou West (HengAn Swiss Hotel). Walk about 80 meters to Dongjian building